Literature DB >> 2388003

Association of serum antibodies to adherence lectin with invasive amebiasis and asymptomatic infection with pathogenic Entamoeba histolytica.

J I Ravdin1, T F Jackson, W A Petri, C F Murphy, B L Ungar, V Gathiram, J Skilogiannis, A E Simjee.   

Abstract

The recognition of the Entamoeba histolytica galactose-inhibitable adherence lectin by antibodies was studied using sera obtained from subjects in South Africa with an amebic liver abscess or asymptomatically pathogenic or nonpathogenic E. histolytica infection and from uninfected regional controls. In addition, sera from healthy American controls or Americans known to be infected with other parasites were studied. Of the 95 sera containing antibodies to total parasite protein, 95% demonstrated antibodies to the 170-kDa heavy subunit but not to the 35-kDa light lectin subunit. All sera (n = 253) were tested by ELISA for antibodies to lectin: 99% from liver abscess patients and all 4 from individuals asymptomatically infected with pathogenic E. histolytica were positive; all from the 40 healthy American controls and the 29 infected with other parasites were negative (P less than .01). The prevalence of serum anti-lectin antibodies was identical (25%) in asymptomatic South Africans with either a nonpathogenic infection or a negative stool culture for E. histolytica. Thus, the presence of serum antibodies to lectin seems to indicate current or prior invasive amebiasis or asymptomatic intestinal infection with pathogenic E. histolytica.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2388003     DOI: 10.1093/infdis/162.3.768

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

1.  Diagnosis of invasive amebiasis by enzyme-linked immunosorbent assay of saliva to detect amebic lectin antigen and anti-lectin immunoglobulin G antibodies.

Authors:  M D Abd-Alla; T F Jackson; S Reddy; J I Ravdin
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Sequence of a cysteine-rich galactose-specific lectin of Entamoeba histolytica.

Authors:  B J Mann; B E Torian; T S Vedvick; W A Petri
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response.

Authors:  Mohamed D Abd-Alla; Terry F G H Jackson; Tyson Rogers; Selvan Reddy; Jonathan I Ravdin
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Neutralizing monoclonal antibody epitopes of the Entamoeba histolytica galactose adhesin map to the cysteine-rich extracellular domain of the 170-kilodalton subunit.

Authors:  B J Mann; C Y Chung; J M Dodson; L S Ashley; L L Braga; T L Snodgrass
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Recombinant antigen-based avidin-biotin microtiter enzyme-linked immunosorbent assay for serodiagnosis of invasive amebiasis.

Authors:  B R Shenai; B L Komalam; A S Arvind; P R Krishnaswamy; P V Rao
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 6.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

7.  Contact-dependent transfer of the galactose-specific lectin of Entamoeba histolytica to the lateral surface of enterocytes in culture.

Authors:  A Leroy; G De Bruyne; M Mareel; C Nokkaew; G Bailey; H Nelis
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

Review 8.  Laboratory diagnosis of amebiasis.

Authors:  Mehmet Tanyuksel; William A Petri
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

Review 9.  Amebic infection in humans.

Authors:  Gourdas Choudhuri; Murali Rangan
Journal:  Indian J Gastroenterol       Date:  2012-08-19

10.  Role of the galactose lectin of Entamoeba histolytica in adherence-dependent killing of mammalian cells.

Authors:  L D Saffer; W A Petri
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.